Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Top Iron Chelation Drug Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Iron Chelation Drug Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Deferoxamine
1.3.3 Deferiprone
1.3.4 Deferasirox
1.4 Market Segment by Application
1.4.1 Global Iron Chelation Drug Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Transfusional Iron Overload
1.4.3 NTDT Caused Iron Overload
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Iron Chelation Drug Revenue (2015-2026)
2.1.1 Global Iron Chelation Drug Revenue (2015-2026)
2.1.2 Global Iron Chelation Drug Sales (2015-2026)
2.2 Iron Chelation Drug Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Iron Chelation Drug Sales by Regions (2015-2020)
2.2.2 Global Iron Chelation Drug Revenue by Regions (2015-2020)
2.3 Global Top Iron Chelation Drug Regions (Countries) Ranking by Market Size
2.4 Iron Chelation Drug Industry Trends
2.4.1 Iron Chelation Drug Market Top Trends
2.4.2 Market Drivers
2.4.3 Iron Chelation Drug Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Iron Chelation Drug Players: Views for Future
3 Competitive Landscape by Manufacturers
3.1 Global Top Iron Chelation Drug Manufacturers by Sales (2015-2020)
3.1.1 Global Iron Chelation Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Iron Chelation Drug Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Iron Chelation Drug Sales in 2019
3.2 Global Top Manufacturers Iron Chelation Drug by Revenue
3.2.1 Global Iron Chelation Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Iron Chelation Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Iron Chelation Drug Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Chelation Drug as of 2019)
3.4 Global Iron Chelation Drug Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Iron Chelation Drug Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Iron Chelation Drug Market
3.7 Key Manufacturers Iron Chelation Drug Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Iron Chelation Drug Historic Market Review by Type (2015-2020)
4.1.2 Global Iron Chelation Drug Sales Market Share by Type (2015-2020)
4.1.3 Global Iron Chelation Drug Revenue Market Share by Type (2015-2020)
4.1.4 Iron Chelation Drug Price by Type (2015-2020)
4.1 Global Iron Chelation Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Iron Chelation Drug Sales Forecast by Type (2021-2026)
4.2.3 Global Iron Chelation Drug Revenue Forecast by Type (2021-2026)
4.2.4 Iron Chelation Drug Price Forecast by Type (2021-2026)
5 Global Iron Chelation Drug Market Size by Application
5.1 Global Iron Chelation Drug Historic Market Review by Application (2015-2020)
5.1.2 Global Iron Chelation Drug Sales Market Share by Application (2015-2020)
5.1.3 Global Iron Chelation Drug Revenue Market Share by Application (2015-2020)
5.1.4 Iron Chelation Drug Price by Application (2015-2020)
5.2 Global Iron Chelation Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Iron Chelation Drug Sales Forecast by Application (2021-2026)
5.2.3 Global Iron Chelation Drug Revenue Forecast by Application (2021-2026)
5.2.4 Iron Chelation Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Iron Chelation Drug Breakdown Data by Company
6.2 North America Iron Chelation Drug Breakdown Data by Type
6.3 North America Iron Chelation Drug Breakdown Data by Application
6.4 North America Iron Chelation Drug Breakdown Data by Countries
6.4.1 North America Iron Chelation Drug Sales by Countries
6.4.2 North America Iron Chelation Drug Revenue by Countries
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Iron Chelation Drug Breakdown Data by Company
7.2 Europe Iron Chelation Drug Breakdown Data by Type
7.3 Europe Iron Chelation Drug Breakdown Data by Application
7.4 Europe Iron Chelation Drug Breakdown Data by Countries
7.4.1 Europe Iron Chelation Drug Sales by Countries
7.4.2 Europe Iron Chelation Drug Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Iron Chelation Drug Breakdown Data by Company
8.2 Asia Pacific Iron Chelation Drug Breakdown Data by Type
8.3 Asia Pacific Iron Chelation Drug Breakdown Data by Application
8.4 Asia Pacific Iron Chelation Drug Breakdown Data by Regions
8.4.1 Asia Pacific Iron Chelation Drug Sales by Regions
8.4.2 Asia Pacific Iron Chelation Drug Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Iron Chelation Drug Breakdown Data by Company
9.2 Latin America Iron Chelation Drug Breakdown Data by Type
9.3 Latin America Iron Chelation Drug Breakdown Data by Application
9.4 Latin America Iron Chelation Drug Breakdown Data by Countries
9.4.1 Latin America Iron Chelation Drug Sales by Countries
9.4.2 Latin America Iron Chelation Drug Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Iron Chelation Drug Breakdown Data by Type
10.2 Middle East and Africa Iron Chelation Drug Breakdown Data by Application
10.3 Middle East and Africa Iron Chelation Drug Breakdown Data by Countries
10.3.1 Middle East and Africa Iron Chelation Drug Sales by Countries
10.3.2 Middle East and Africa Iron Chelation Drug Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E
11 Company Profiles
11.1 Apotex Inc. (Canada)
11.1.1 Apotex Inc. (Canada) Corporation Information
11.1.2 Apotex Inc. (Canada) Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Apotex Inc. (Canada) Iron Chelation Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Apotex Inc. (Canada) Iron Chelation Drug Products and Services
11.1.5 Apotex Inc. (Canada) SWOT Analysis
11.1.6 Apotex Inc. (Canada) Recent Developments
11.2 Cipla (India)
11.2.1 Cipla (India) Corporation Information
11.2.2 Cipla (India) Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Cipla (India) Iron Chelation Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Cipla (India) Iron Chelation Drug Products and Services
11.2.5 Cipla (India) SWOT Analysis
11.2.6 Cipla (India) Recent Developments
11.3 Novartis (Switzerland)
11.3.1 Novartis (Switzerland) Corporation Information
11.3.2 Novartis (Switzerland) Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Novartis (Switzerland) Iron Chelation Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Novartis (Switzerland) Iron Chelation Drug Products and Services
11.3.5 Novartis (Switzerland) SWOT Analysis
11.3.6 Novartis (Switzerland) Recent Developments
11.4 Sun Pharma (India)
11.4.1 Sun Pharma (India) Corporation Information
11.4.2 Sun Pharma (India) Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Sun Pharma (India) Iron Chelation Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Sun Pharma (India) Iron Chelation Drug Products and Services
11.4.5 Sun Pharma (India) SWOT Analysis
11.4.6 Sun Pharma (India) Recent Developments
11.5 Natco Pharma (India)
11.5.1 Natco Pharma (India) Corporation Information
11.5.2 Natco Pharma (India) Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Natco Pharma (India) Iron Chelation Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Natco Pharma (India) Iron Chelation Drug Products and Services
11.5.5 Natco Pharma (India) SWOT Analysis
11.5.6 Natco Pharma (India) Recent Developments
12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Iron Chelation Drug Sales Channels
12.2.2 Iron Chelation Drug Distributors
12.3 Iron Chelation Drug Customers
13 Estimates and Projections by Regions (2021-2026)
13.1 Global Iron Chelation Drug Sales Forecast (2021-2026)
13.1.1 Global Iron Chelation Drug Sales Forecast by Regions (2021-2026)
13.1.2 Global Iron Chelation Drug Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Iron Chelation Drug Sales Forecast (2021-2026)
13.2.2 North America Iron Chelation Drug Revenue Forecast (2021-2026)
13.2.3 North America Iron Chelation Drug Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Iron Chelation Drug Sales Forecast (2021-2026)
13.3.2 Europe Iron Chelation Drug Revenue Forecast (2021-2026)
13.3.3 Europe Iron Chelation Drug Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Iron Chelation Drug Sales Forecast (2021-2026)
13.4.2 Asia Pacific Iron Chelation Drug Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Iron Chelation Drug Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Iron Chelation Drug Sales Forecast (2021-2026)
13.5.2 Latin America Iron Chelation Drug Revenue Forecast (2021-2026)
13.5.3 Latin America Iron Chelation Drug Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Iron Chelation Drug Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Iron Chelation Drug Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Iron Chelation Drug Size Forecast by County (2021-2026)
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
【掲載企業】
Apotex Inc. (Canada)、Cipla (India)、Novartis (Switzerland)、Sun Pharma (India)、Natco Pharma (India)
【免責事項】
https://www.globalresearch.jp/disclaimer